The Oxford Risk Factors And Non-Invasive Imaging Study — StellaTrial locations(37 sites)
United States
NIH National Heart, Lunch, and Blood Institute, Bethesda, Maryland Mayo Clinic, Rochester, Minnesota Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio Australia
Flinders University, Adelaide The University of Sydney, Sydney Belgium
University Hospitals Leuven, Leuven China
Fudan University, Shanghai TEDA International Cardiovascular Hospital, Tianjin France
Almaviva Sante - Clinique Axium, Aix-en-Provence Germany
Friedrich-Alexander-Universitat Erlangen-Nurmberg, Erlangen University Hospital Ulm, Ulm Greece
Lefkos Stavros Clinic, Athens Hungary
MTA-SE Cardiovascular Imaging Research Group, Budapest Italy
Centro Cardiologico Monzino IRCCS, University of Milan, Milan Netherlands
Amsterdam Universitair Medische Centra, Amsterdam Zuyderland Medical Centre, Sittard Romania
University of Medicine and Pharmacy of Targu Mures, Târgu Mureş South Korea
Seoul National University, Seoul United Arab Emirates
Cleveland Clinic Abu Dhabi, Abu Dhabi United Kingdom
Royal United Hospitals Bath NHS Foundation Trust, Bath Sandwell and West Birmingham Hospitals NHS Trust, Birmingham University Hospitals Birmingham NHS Trust, Birmingham Royal Papworth Hospital NHS Trust, Cambridge University of Edinburgh, Royal Infirmary, Edinburgh Golden Jubilee National Hospital, Glasgow NHS Greater Glasgow and Clyde, Glasgow Leeds Teaching Hospitals NHS Trust, Leeds University Hosptials of Leicester NHS Trust, Leicester Liverpool Heart and Chest Hospital, Liverpool Barts Health NHS Trust, London Guy's and St Thomas' NHS Foundation Trust, London Royal Brompton and Harefield Hospitals, London University Hospital of Manchester NHS Foundation Trust, Manchester
Milton Keynes University Hospital, Milton Keynes Oxford University Hospitals NHS Foundation Trust, Oxford Heart and Lung Centre, New Cross Hospital, Wolverhampton